Zika Virus: Pharma’s New Cash Cow!

By Christopher Wyatt | TLB staff writer/documentary producer

Anyone who who has watched the news as of late has heard of the Zika virus and all its dangers. Why is this? Could it be because they are working on a vaccine? On Tuesday April 19th, 2016 President Obama signed S. 2512, the “Adding Zika Virus to the FDA Priority Review Voucher Program Act” which allows for this vaccine to be fast tracked and a vaccine trial ready for September of 2016.

Check out the article below to see why this is a cash cow for vaccine makers.

by GEN News Highlights

Protein Sciences, Sinergium Partner with Foundation to Develop Zika Vaccine

“Protein Sciences, Sinergium Biotech, and the private foundation Mundo Sano said today they will form a consortium to jointly develop a vaccine against the Zika virus.

The value of the collaboration was not disclosed. Sinergium agreed to pay an upfront fee to fund development and manufacture of the vaccine being produced at Protein Sciences. The vaccine will be produced using the technology of Protein Sciences, whose FDA-approved Flublok is the world’s first recombinant protein-based vaccine for prevention of seasonal influenza disease.

In return, Sinergium will receive manufacturing and commercial rights to the vaccine in Argentina and other counties to be determined. The companies also said they are in “active” discussions with additional strategic partners worldwide, with the goal of strengthening and rapidly advancing the development program.

The partners plan to develop a vaccine based on recombinant variations of the E protein from the Zika virus. Protein Sciences has produced similar vaccine candidates against West Nile virus and Japanese encephalitis virus. Both candidates were shown to neutralize their respective viruses in preclinical studies.

Protein Sciences CEO Manon Cox speaks to a reporter in Pearl River, N.Y., Tuesday, Aug. 18, 2015. Protein Sciences is among the companies working on more vaccine options for the coming flu season. (AP Photo/Seth Wenig)
Protein Sciences CEO Manon Cox (AP Photo/Seth Wenig)

“We initiated Zika vaccine development in February and are rapidly advancing vaccine candidates to the clinic,” Protein Sciences President and CEO Manon M.J. Cox, Ph.D., said in a statement.

She added that Sinergium’s proximity to the heart of the outbreak “opens up channels of support that would otherwise be inaccessible.” The company owns a 20,000 square-meter (215,278-square-foot) production facility in Garin, Buenos Aires, Argentina, and manufactures more than 13 million doses of vaccines that include seasonal influenza, pneumococcal and HPV.

Mundo Sano aims to promote and create conditions that improve the health of people exposed to neglected diseases, working in Argentina, Spain, and Africa.”


In my opinion this vaccine is going to be dangerous like all other vaccines, already you have pro vaccine scientist saying that this vaccine will come with serious risk. (CW)



TLB recommends other health articles from GEN News Highlights

TLB has other above the fold articles, videos and stories available by clicking on “HOME” at the top of this post. Never miss a new post, sign up for E-Mail alerts at the bottom of the Home page and get a link dropped right to your in-box.

1 Comment on Zika Virus: Pharma’s New Cash Cow!

  1. Whooping cough is a bacteria that colonises the throat, called pertussis.
    1. Near no pertussis Australia whole cell pertussis vaccine (wP) 1953-1995
    2. Change to aP vaccine 1996.
    3. Vaccination rate, all time high levels of over 90%
    4. First Major outbreaks begin 2010, when all first aP vaccinated show 100% failure rates of the vaccine.
    5. No one over age 12 catches the illness, in the outbreak in 2010, one has to assume the whole cell is still working in anyone who got vaccinated prior to 1996.
    6. WA Health Department discover those kids aged 6-12 who they test, during the outbreak in 2010, although showing no symptoms still had pertussis bacteria in their throats for up to 8 weeks, and were able to transmit this to others. These children had still working aP vaccine, which protected them, but did not stop them transmitting the bacteria.
    7. Studies prove that fully vaccinated, with no symptoms, who have not yet had pertussis themselves (when the vaccine fails), do in fact, still catch, carry and spread pertussis to infants, who are too young to be vaccinated..
    8. In an attempt to prevaccinated babies, USA recommends aP vaccine be given to all pregnant women in 2013. Rise from 5,000 microcephalic babies per year to over 25,000 per year.
    9. Introduce aP vaccination to all Brazilian pregnant women in May 2015, first babies born October, a rise to 12,000 babies per year with microcephaly, which is less than the present rate in USA.
    10. No zika in USA to blame, so how do CDC explain this rise in microcephaly?

    [email protected]

Leave a Reply

Your email address will not be published.